Autophagy and oxidative stress modulation mediate Bortezomib resistance in prostate cancer.
Proteasome inhibitors such as Bortezomib represent an established type of targeted treatment for several types of hematological malignancies, including multiple myeloma, Waldenstrom's macroglobulinemia, and mantle cell lymphoma, based on the cancer cell's susceptibility to impairment of the proteaso...
Shranjeno v:
| Principais autores: | , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Public Library of Science (PLoS)
2024-01-01
|
| Serija: | PLoS ONE |
| Online dostop: | https://doi.org/10.1371/journal.pone.0289904 |
| Oznake: |
Brez oznak, prvi označite!
|